Seven months have passed since our incorporation last December, and we are pleased to report significant progress. In these complex times, our company and every one of our employees are working diligently toward a new dimension of medicine that no one has yet explored.

Here are the two key updates on our business activities for the second quarter.

1. R&D in the Obstetrics and Gynecology Field

We were aiming to complete our prototype by the end of June. However, due to a delay in procuring some components and the development of new features and patentable inventions, the prototype was finalized at the end of July. We expect to complete all non-clinical evaluations by mid-August. While there has been a slight delay, we consider it a positive one that will benefit our future endeavors.

2. Consulting Business

Thanks to the strong reception, we now have six projects running simultaneously, starting with our very first client. We've also begun negotiations with potential clients in the drug discovery field, aiming to diversify our services. Furthermore, we've received an order from a client in India, which is helping us to further our international expansion.

Japan is currently experiencing a severe heatwave.

Please take care of yourselves.